About: http://data.cimple.eu/news-article/ae29f0cf337d55920e23ba07b95f9d941cf91aa2236ad3778adce948     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

AttributesValues
rdf:type
schema:articleBody
  • American authorities announced on Sunday an emergency authorization for doctors to use blood plasma from recovered coronavirus patients as a treatment against the disease that has killed over 176,000 in the US. The move by the Food and Drug Administration comes as President Donald Trump faces intense pressure to curb the contagion that has hobbled the world's largest economy and clouded his once-promising prospects for re-election in November. The plasma is believed to contain powerful antibodies that can help fight off the disease faster and help protect people from being seriously hurt by it. "This product may be effective in treating COVID-19 and... the known and potential benefits of the product outweigh the known and potential risks of the product," FDA said in a statement. While the treatment has already been used on patients in the United States and other nations, the extent of its effectiveness is still debated by experts and some have warned that it could carry side effects. "Convalescent plasma probably works -- though it still needs to be proven in clinical trials -- but not as a rescue treatment for people who are already severely ill," said Len Horovitz, a pulmonary specialist at Lenox Hill Hospital in New York City. He said that plasma would likely work much better right after a person was exposed to the virus, when the body is trying to neutralize the infection -- the problem being that plasma supplies are limited, meaning it would be difficult to get enough to treat everyone in early stages of the disease. Trump told reporters the therapy shows "an incredible rate of success" and "will save countless lives", but this went much further than his own health officials' cautious welcome of the treatment. Challenged by a reporter to explain the apparent contradiction, Trump passed the question to one of his experts, then ended the press conference. The FDA already allowed convalescent plasma transfusions for coronavirus patients under certain conditions, such as clinical trials and gravely ill people. The Washington Post said that over 70,000 virus patients in the US have received such a transfusion. Trump has been widely criticized for his handling of the coronavirus pandemic in the US, which remains the world leader in infections and fatalities. He faces a tough re-election battle against Democratic challenger Joe Biden, with no effective treatment or vaccine expected before the vote on November 3. bur-st/jm
schema:headline
  • US authorizes plasma treatment against virus
schema:mentions
schema:author
schema:datePublished
http://data.cimple...sPoliticalLeaning
http://data.cimple...logy#hasSentiment
http://data.cimple...readability_score
http://data.cimple...tology#hasEmotion
Faceted Search & Find service v1.16.115 as of Oct 09 2023


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 3 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software